FI951388L - Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as pharmaceuticals - Google Patents
Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as pharmaceuticals Download PDFInfo
- Publication number
- FI951388L FI951388L FI951388A FI951388A FI951388L FI 951388 L FI951388 L FI 951388L FI 951388 A FI951388 A FI 951388A FI 951388 A FI951388 A FI 951388A FI 951388 L FI951388 L FI 951388L
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceuticals
- preparation
- carboxylic acid
- acid amide
- substituted heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410453A DE4410453A1 (en) | 1994-03-25 | 1994-03-25 | Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as medicaments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI951388A0 FI951388A0 (en) | 1995-03-23 |
| FI951388L true FI951388L (en) | 1995-09-26 |
| FI951388A7 FI951388A7 (en) | 1995-09-26 |
Family
ID=6513880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951388A FI951388A7 (en) | 1994-03-25 | 1995-03-23 | Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as pharmaceuticals |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0673930A1 (en) |
| JP (1) | JPH07278111A (en) |
| KR (1) | KR950032127A (en) |
| AU (1) | AU1504495A (en) |
| CA (1) | CA2145473A1 (en) |
| CZ (1) | CZ73595A3 (en) |
| DE (1) | DE4410453A1 (en) |
| FI (1) | FI951388A7 (en) |
| HU (1) | HUT72596A (en) |
| NO (1) | NO951147L (en) |
| PL (1) | PL307846A1 (en) |
| ZA (1) | ZA952410B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0206711D0 (en) | 2002-03-21 | 2002-05-01 | Isis Innovation | HIF Inhibitor |
| WO2008061236A2 (en) * | 2006-11-16 | 2008-05-22 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| US8558002B2 (en) | 2006-11-16 | 2013-10-15 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| KR102336926B1 (en) | 2014-10-06 | 2021-12-08 | 버텍스 파마슈티칼스 인코포레이티드 | Modulators of cystic fibrosis transmembrane conductance regulator |
| EP3436446B1 (en) | 2016-03-31 | 2023-06-07 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| UA124708C2 (en) | 2016-09-30 | 2021-11-03 | Вертекс Фармасьютікалз Інкорпорейтед | MODULATOR OF THE MUSCULAR FISCOSE REGULATOR OF TRANSMEMBRANE CONDUCTANCE, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT AND METHOD OF OBTAINING THE MODULATOR |
| AU2017371200B2 (en) | 2016-12-09 | 2021-05-06 | Vertex Pharmaceuticals Incorporated | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| MA54105A (en) | 2017-06-08 | 2021-09-15 | Vertex Pharma | CYSTIC FIBROSIS TREATMENT METHODS |
| MA49631A (en) | 2017-07-17 | 2020-05-27 | Vertex Pharma | CYSTIC FIBROSIS TREATMENT METHODS |
| KR102606188B1 (en) | 2017-08-02 | 2023-11-23 | 버텍스 파마슈티칼스 인코포레이티드 | Process for producing pyrrolidine compounds |
| US10654829B2 (en) | 2017-10-19 | 2020-05-19 | Vertex Pharmaceuticals Incorporated | Crystalline forms and compositions of CFTR modulators |
| US11465985B2 (en) | 2017-12-08 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
| TWI810243B (en) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | Pharmaceutical compositions for treating cystic fibrosis |
| US11414439B2 (en) | 2018-04-13 | 2022-08-16 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410453A patent/DE4410453A1/en not_active Withdrawn
-
1995
- 1995-03-09 EP EP95103405A patent/EP0673930A1/en not_active Withdrawn
- 1995-03-23 CZ CZ95735A patent/CZ73595A3/en unknown
- 1995-03-23 FI FI951388A patent/FI951388A7/en unknown
- 1995-03-23 AU AU15044/95A patent/AU1504495A/en not_active Abandoned
- 1995-03-24 CA CA002145473A patent/CA2145473A1/en not_active Abandoned
- 1995-03-24 HU HU9500863A patent/HUT72596A/en unknown
- 1995-03-24 PL PL95307846A patent/PL307846A1/en unknown
- 1995-03-24 ZA ZA952410A patent/ZA952410B/en unknown
- 1995-03-24 NO NO951147A patent/NO951147L/en unknown
- 1995-03-24 JP JP7065927A patent/JPH07278111A/en active Pending
- 1995-03-25 KR KR1019950006806A patent/KR950032127A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07278111A (en) | 1995-10-24 |
| CA2145473A1 (en) | 1995-09-26 |
| DE4410453A1 (en) | 1995-09-28 |
| EP0673930A1 (en) | 1995-09-27 |
| FI951388A7 (en) | 1995-09-26 |
| NO951147D0 (en) | 1995-03-24 |
| KR950032127A (en) | 1995-12-20 |
| AU1504495A (en) | 1995-10-05 |
| CZ73595A3 (en) | 1995-11-15 |
| ZA952410B (en) | 1995-12-01 |
| HUT72596A (en) | 1996-05-28 |
| PL307846A1 (en) | 1995-10-02 |
| NO951147L (en) | 1995-09-26 |
| FI951388A0 (en) | 1995-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971529L (en) | New carboxylic acid derivatives, their preparation and use | |
| FI941082L (en) | Quinolone carboxylic acid derivatives, their preparation and use | |
| FI960933A7 (en) | Carboxylic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents | |
| FI963298L (en) | Hydroxemic acid and carboxylic acid derivatives, method for their preparation and use | |
| EE200100258A (en) | Anthranilic acid amides and their use as medicaments | |
| HUP9903405A3 (en) | Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids with metalloproteinase inhibitor activity, preparation and use thereof | |
| FI943948L (en) | Heterocyclic carboxylic acid derivatives | |
| NO924978D0 (en) | CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES | |
| FI951387A7 (en) | Sulfonamidocarbonylpyridine-2-carboxylic acid ester amides and their pyridine-N-oxides, process for their preparation and their use as pharmaceuticals | |
| FI951771A7 (en) | New delta-amino-gamma-hydroxy-omega-arylalkanoic acid amides | |
| DE59706602D1 (en) | 3-Hydroxy-pyridine-2-carboxylic acid amide esters, their preparation and their use as medicaments | |
| FI951388L (en) | Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as pharmaceuticals | |
| FI955836A7 (en) | Aromatically substituted omega-aminoalkanoic acid amides and alkanoic acid diamides | |
| FI940216A7 (en) | Quinolone and naphthyridonecarboxylic acid derivatives | |
| EE9500059A (en) | Use of substituted 4-phenyl-6-aminonicotinic acid derivatives as medicaments | |
| FI963885L (en) | Pyrimidine or triazinecarboxylic acid derivatives for use as pharmaceuticals | |
| FI964482L (en) | Amide derivatives and their use as medicine | |
| AU4257096A (en) | Substituted carboxylic acid amides and their use as fungicides | |
| FI924779A7 (en) | N-phenyl-2-cyano-3-hydroxycrotonic acid amide derivatives and their use as pharmaceuticals with immunomodulatory properties | |
| FI953956L (en) | 2,3-Ring-fused 1,4-dihydropyridines, methods for their preparation and their use as pharmaceuticals | |
| FI925850A7 (en) | Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses | |
| FI954680L (en) | Quinolone and naphthyridonecarboxylic acid derivatives | |
| FI941380A7 (en) | Phenylglycine amides of heterocyclic substituted phenylacetic acid derivatives | |
| FI925467L (en) | Quinolylmethoxyphenyl lactic acid amide | |
| FI951385A7 (en) | Substituted heterocyclic carboxylic acid amides, their preparation and their use as pharmaceuticals |